株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

薬物スクリーニングの世界市場 (〜2022年):製品・サービス (イムノアッセイアナライザー・クロマトグラフィ・呼気分析装置・迅速検査機器・アッセイキット・試薬)・サンプルタイプ (尿・毛髪・口腔)・エンドユーザー別

Drug Screening Market by Product ((Immunoassay Analyzer, Chromatography, Breathalyzer, Rapid Test Device, Assay Kits)),Drug Screening Services,Sample Type (Urine,Hair,Oral),End User (Workplace, Criminal Justice, Hospital) - Global Forecast to 2022

発行 MarketsandMarkets 商品コード 327644
出版日 ページ情報 英文 205 Pages
即納可能
価格
本日の銀行送金レート: 1USD=108.52円で換算しております。
Back to Top
薬物スクリーニングの世界市場 (〜2022年):製品・サービス (イムノアッセイアナライザー・クロマトグラフィ・呼気分析装置・迅速検査機器・アッセイキット・試薬)・サンプルタイプ (尿・毛髪・口腔)・エンドユーザー別 Drug Screening Market by Product ((Immunoassay Analyzer, Chromatography, Breathalyzer, Rapid Test Device, Assay Kits)),Drug Screening Services,Sample Type (Urine,Hair,Oral),End User (Workplace, Criminal Justice, Hospital) - Global Forecast to 2022
出版日: 2018年01月15日 ページ情報: 英文 205 Pages
概要

薬物スクリーニングの市場規模は2017年から2022年にかけて10.2%のCAGRで推移し、2017年の53億2,000万米ドルから、2022年には86億3,000万米ドルの規模に成長すると予測されています。この成長の主な要因には、薬物およびアルコール消費の増加、薬物・アルコール検査を義務付ける厳しい法律の強化、および主要市場における政府の財政支援の存在などがあげられます。

当レポートでは、世界の薬物スクリーニングの市場について調査し、市場の背景と市場成長への各種影響因子の分析、関連の検査機器、消耗品、サービスの酒類と概要、製品およびサービス・サンプル・エンドユーザー別の市場規模の推移と予測、地域および主要国別の動向、競合環境と市場シェア、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 市場成長推進因子
    • 市場成長阻害因子
    • 市場機会
    • 課題

第6章 薬物スクリーニング市場:製品・サービス別

  • イントロダクション
  • 薬物スクリーニング製品
    • 分析機器
      • イムノアッセイ分析装置
      • クロマトグラフィー機器
      • 呼気呼気分析装置
    • 迅速検査装置
      • 尿検査
      • 口腔液検査装置
    • 消耗品
      • アッセイキット
      • サンプル採取カップ
      • キャリブレーター&コントロール
      • その他
  • 薬物スクリーニングサービス

第7章 薬物スクリーニング市場:サンプルタイプ別

  • イントロダクション
  • 尿
  • 呼気
  • 口腔液
  • 毛髪
  • その他

第8章 薬物スクリーニング市場:エンドユーザー別

  • イントロダクション
  • 職場
  • 刑事司法制度・ 法執行機関
  • 薬物治療センター
  • 疼痛管理センター
  • 学校
  • 病院
  • 個人利用
  • 薬物検査ラボ

第9章 第地域分析

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
  • アジア太平洋
  • その他

10章 競合環境 ▼イントロダクション ▼主要企業ランキング (迅速検査装置) ▼主要企業ランキング (薬物スクリーニングサービス) ▼競合シナリオ ▼新製品の発表・承認 ▼拡張 ▼合意・提携・競合 ▼買収

第11章 企業プロファイル

  • ALERE
  • THERMO FISHER SCIENTIFIC
  • DRAGERWERK
  • LABCORP
  • QUEST DIAGNOSTICS
  • ALFA SCIENTIFIC DESIGNS
  • LIFELOC
  • MPD INC.
  • ORASURE
  • OMEGA LABORATORIES
  • PREMIER BIOTECH
  • PSYCHEMEDICS
  • ROCHE
  • 島津製作所
  • SIEMENS HEALTHINEERS

第12章 付録

目次
Product Code: MD 3239

"Global drug screening market projected to grow at a CAGR of 10.2% during the forecast period"

The drug screening market is expected to reach USD 8.63 billion million by 2022 from USD 5.32 billion in 2017, at a CAGR of 10.2%. Growing drug & alcohol consumption, enforcement of stringent laws mandating drug and alcohol testing, and the presence of government funding in major markets are factors driving the growth of the drug screening market. On the other hand, market growth may be limited to a certain extent due to the prohibition of workplace drug testing in some countries and the ban on alcohol consumption in several Islamic countries.

"Drug screening services are expected to grow at the highest CAGR during the forecast period"

Drug screening market is segmented into products and services. The services segment is projected to register the highest CAGR during the forecast period, growth in this segment is attributed to factors such as the growing drug and alcohol consumption worldwide, funding initiatives for drug testing laboratories, new and regular service launches and regulatory approvals, and the geographic expansion of drug and alcohol testing laboratories.

"By sample type, urine samples are expected to dominate the market during the forecast period"

The drug screening market is segmented into urine, breath, hair, oral, and other samples on the basis of sample type. The urine sample segment is expected to dominate the market during the forecast period due to the benefits it offers such as high accuracy in the detection of multiple drugs, cost-effectiveness, and instant results.

"Asia Pacific to witness high growth during the forecast period"

In 2017, North America is expected to account for the largest share of the market followed by Europe. However, Asia is expected to register the highest CAGR during the forecast period. The high growth in this regional segment is attributed to the growing consumption of illicit drugs, rising number of drunk-driving cases, growing awareness regarding drug screening tests and the strategic expansion of the market players in the region.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 - 23%; Tier 2 - 32%; Tier 3 - 45%.
  • By Designation: C-level- 21%; D-level- 36%; others--43%.
  • By Region: North America-42%; Europe-37%; Asia Pacific-17%; RoW-4%.

List of companies profiled in the report:

  • Alere (US)
  • Thermo Fisher (US)
  • Dragerwerk (Germany)
  • LabCorp (US)
  • Quest Diagnostics (US)
  • Alfa Scientific Designs (US)
  • Lifeloc (US)
  • MPD, Inc. (US)
  • OraSure (US)
  • Omega Laboratories (US)
  • Premier Biotech (US)
  • Psychemedics (US)
  • Roche (Switzerland)
  • Shimadzu (Japan)
  • Seimens Healthineers (US)

Research Coverage:

The report provides an overview of the drug screening market. It aims at estimating the market size and growth potential of this market across different segments such as product and service, sample type, end user, and region. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help the market leaders/new entrants in the drug screening market by providing them with the closest approximations of revenues for the overall market and its subsegments. This report will help stakeholders to understand the competitive landscape better and gain insights to position their businesses and help companies adopt suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provide them with information regarding key market drivers and opportunities.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. MARKET STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
  • 2.2. SECONDARY DATA
    • 2.2.1. SECONDARY SOURCES
  • 2.3. PRIMARY DATA
    • 2.3.1. PRIMARY SOURCES
    • 2.3.2. KEY INDUSTRY INSIGHTS
  • 2.4. MARKET ESTIMATION
  • 2.5. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.6. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. ATTRACTIVE OPPORTUNITIES IN DRUG SCREENING MARKET
  • 4.2. DRUG SCREENING MARKET, BY PRODUCT
  • 4.3. GEOGRAPHICAL ANALYSIS EUROPE DRUG SCREENING MARKET, BY PRODUCT AND COUNTRY
  • 4.4. DRUG SCREENING MARKET, BY SAMPLE TYPE
  • 4.5. DRUG SCREENING MARKET, BY END USER
  • 4.6. DRUG SCREENING MARKET: GEOGRAPHIC SNAPSHOT

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Growing drug & alcohol consumption
      • 5.2.1.2. Enforcement of stringent laws mandating drug and alcohol testing
      • 5.2.1.3. Presence of government funding in major markets
      • 5.2.1.4. Regulatory approvals & product launches and services
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Ban on alcohol consumption in several Islamic countries
      • 5.2.2.2. Prohibition of workplace drug testing in some countries
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Oral fluid testing
      • 5.2.3.2. Emergence of fingerprint-based drug screening
      • 5.2.3.3. Emerging economies
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Accuracy and specificity concerns related to breathalyzers

6. DRUG SCREENING MARKET, BY PRODUCT & SERVICE

  • 6.1. INTRODUCTION
  • 6.2. DRUG SCREENING PRODUCTS
    • 6.2.1. ANALYTICAL INSTRUMENTS
      • 6.2.1.1. Immunoassay analyzers
      • 6.2.1.2. Chromatography instruments
      • 6.2.1.3. Breathalyzers
        • 6.2.1.3.1. Fuel cell breathalyzers
        • 6.2.1.3.2. Semiconductor breathalyzers
        • 6.2.1.3.3. Other breathalyzers
    • 6.2.2. RAPID TESTING DEVICES
      • 6.2.2.1. Urine testing devices
        • 6.2.2.1.1. Drug testing cups
        • 6.2.2.1.2. Dip cards
        • 6.2.2.1.3. Drug testing cassettes
      • 6.2.2.2. Oral fluid testing devices
    • 6.2.3. CONSUMABLES
      • 6.2.3.1. Assay kits
      • 6.2.3.2. Sample collection devices
      • 6.2.3.3. Calibrators and controls
      • 6.2.3.4. Other consumables
  • 6.3. DRUG SCREENING SERVICES

7. DRUG SCREENING MARKET, BY SAMPLE TYPE

  • 7.1. INTRODUCTION
  • 7.2. URINE SAMPLES
  • 7.3. BREATH SAMPLES
  • 7.4. ORAL FLUID SAMPLES
  • 7.5. HAIR SAMPLES
  • 7.6. OTHER SAMPLES

8. DRUG SCREENING MARKET, BY END USER

  • 8.1. INTRODUCTION
  • 8.2. WORKPLACE
  • 8.3. CRIMINAL JUSTICE SYSTEMS AND LAW ENFORCEMENT AGENCIES
  • 8.4. DRUG TREATMENT CENTERS
  • 8.5. PAIN MANAGEMENT CENTERS
  • 8.6. SCHOOLS AND COLLEGES
  • 8.7. HOSPITALS
  • 8.8. INDIVIDUAL USERS
  • 8.9. DRUG TESTING LABORATORIES

9. DRUG SCREENING MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. US
    • 9.2.2. CANADA
  • 9.3. EUROPE
    • 9.3.1. GERMANY
    • 9.3.2. FRANCE
    • 9.3.3. UK
    • 9.3.4. REST OF EUROPE (ROE)
  • 9.4. ASIA PACIFIC
  • 9.5. REST OF THE WORLD (ROW)

10. COMPETITIVE LANDSCAPE

  • 10.1. INTRODUCTION
  • 10.2. RAPID TESTING DEVICES, RANKING OF KEY PLAYER (2016)
  • 10.3. DRUG SCREENING SERVICES MARKET, RANKING OF KEY PLAYER (2016)
  • 10.4. COMPETITIVE SCENARIO
    • 10.4.1. PRODUCT LAUNCHES AND APPROVALS
    • 10.4.2. EXPANSIONS
    • 10.4.3. AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
    • 10.4.4. ACQUISITIONS

11. COMPANY PROFILES (Business Overview, Products Offered, Swot Anlysis, MnM View.)*

  • 11.1. ALERE
  • 11.2. THERMO FISHER SCIENTIFIC
  • 11.3. DRAGERWERK
  • 11.4. LABCORP
  • 11.5. QUEST DIAGNOSTICS
  • 11.6. ALFA SCIENTIFIC DESIGNS
  • 11.7. LIFELOC
  • 11.8. MPD INC.
  • 11.9. ORASURE
  • 11.10. OMEGA LABORATORIES
  • 11.11. PREMIER BIOTECH
  • 11.12. PSYCHEMEDICS
  • 11.13. ROCHE
  • 11.14. SHIMADZU
  • 11.15. SIEMENS HEALTHINEERS

*Business Overview, Products Offered, Swot Anlysis, MnM View might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. INSIGHTS FORM INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.5. AVAILABLE CUSTOMIZATIONS
  • 12.6. RELATED REPORTS
  • 12.7. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: KEY PRODUCT & SERVICE LAUNCHES (2014-2017)
  • TABLE 2: RECENT APPROVALS FOR DRUG AND ALCOHOL TESTING PRODUCTS AND SERVICES
  • TABLE 3: DRUG SCREENING MARKET: STAREGIC DEVELOPMENTS IN EMERGING MARKETS
  • TABLE 4: DRUG SCREENING PRODUCTS & SERVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 5: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 6: DRUG SCREENING PRODUCTS MARKET FOR ANALYTICAL INSTRUMENTS, BY, TYPE, 2015-2022 (USD MILLION)
  • TABLE 7: DRUG SCREENING PRODUCTS MARKET FOR ANALYTICAL INSTRUMENTS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 8: NORTH AMERICA: DRUG SCREENING PRODUCTS MARKET FOR ANALYTICAL INSTRUMENTS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 9: EUROPE: DRUG SCREENING PRODUCTS MARKET FOR ANALYTICAL INSTRUMENTS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 10: IMMUNOASSAY ANALYZERS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 11: NORTH AMERICA: IMMUNOASSAY ANALYZERS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 12: EUROPE: IMMUNOASSAY ANALYZERS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 13: CHROMATOGRAPHY INSTRUMENTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 14: NORTH AMERICA: CHROMATOGRAPHY INSTRUMENTS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 15: EUROPE: CHROMATOGRAPHY INSTRUMENTS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 16: BREATHALYZERS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 17: BREATHALYZERS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 18: NORTH AMERICA: BREATHALYZERS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 19: EUROPE: BREATHALYZERS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 20: FUEL CELL BREATHALYZERS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 21: NORTH AMERICA: FUEL CELL BREATHALYZERS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 22: EUROPE: FUEL CELL BREATHALYZERS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 23: SEMICONDUCTOR BREATHALYZERS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 24: NORTH AMERICA: SEMICONDUCTOR BREATHALYZERS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 25: EUROPE: SEMICONDUCTOR BREATHALYZERS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 26: OTHER BREATHALYZERS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 27: NORTH AMERICA: OTHER BREATHALYZERS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 28: EUROPE: OTHER BREATHALYZERS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 29: DRUG SCREENING PRODUCTS MARKET FOR RAPID TESTING DEVICES, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 30: DRUG SCREENING PRODUCTS MARKET FOR RAPID TESTING DEVICES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 31: NORTH AMERICA: DRUG SCREENING PRODUCTS MARKET FOR RAPID TESTING DEVICES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 32: EUROPE: DRUG SCREENING PRODUCTS MARKET FOR RAPID TESTING DEVICES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 33: URINE TESTING DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 34: URINE TESTING DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 35: NORTH AMERICA: URINE TESTING DEVICES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 36: EUROPE: URINE TESTING DEVICES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 37: DRUG TESTING CUPS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 38: NORTH AMERICA: DRUG TESTING CUPS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 39: EUROPE: DRUG TESTING CUPS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 40: DIP CARDS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 41: NORTH AMERICA: DIP CARDS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 42: EUROPE: DIP CARDS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 43: DRUG TESTING CASSETTES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 44: NORTH AMERICA: DRUG TESTING CASSETTES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 45: EUROPE: DRUG TESTING CASSETTES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 46: ORAL FLUID TESTING DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 47: NORTH AMERICA: ORAL FLUID TESTING DEVICES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 48: EUROPE: ORAL FLUID TESTING DEVICES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 49: DRUG SCREENING CONSUMABLES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 50: DRUG SCREENING CONSUMABLES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 51: NORTH AMERICA: DRUG SCREENING CONSUMABLES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 52: EUROPE: DRUG SCREENING CONSUMABLES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 53: ASSAY KITS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 54: NORTH AMERICA: ASSAY KITS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 55: EUROPE: ASSAY KITS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 56: SAMPLE COLLECTION DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 57: NORTH AMERICA: SAMPLE COLLECTION DEVICES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 58: EUROPE: SAMPLE COLLECTION DEVICES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 59: CALIBRATORS AND CONTROLS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 60: NORTH AMERICA: CALIBRATORS AND CONTROLS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 61: EUROPE: CALIBRATORS AND CONTROLS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 62: OTHER CONSUMABLES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 63: NORTH AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 64: EUROPE: OTHER CONSUMABLES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 65: DRUG SCREENING SERVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 66: NORTH AMERICA: DRUG SCREENING SERVICES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 67: EUROPE: DRUG SCREENING SERVICES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 68: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
  • TABLE 69: DRUG SCREENING MARKET FOR URINE SAMPLES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 70: NORTH AMERICA: DRUG SCREENING MARKET FOR URINE SAMPLES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 71: EUROPE: DRUG SCREENING MARKET FOR URINE SAMPLES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 72: DRUG SCREENING MARKET FOR BREATH SAMPLES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 73: NORTH AMERICA: DRUG SCREENING MARKET FOR BREATH SAMPLES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 74: EUROPE: DRUG SCREENING MARKET FOR BREATH SAMPLES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 75: DRUG SCREENING MARKET FOR ORAL FLUID SAMPLES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 76: NORTH AMERICA: DRUG SCREENING MARKET FOR ORAL FLUID SAMPLES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 77: EUROPE: DRUG SCREENING MARKET FOR ORAL FLUID SAMPLES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 78: DRUG SCREENING MARKET FOR HAIR SAMPLES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 79: NORTH AMERICA: DRUG SCREENING MARKET FOR HAIR SAMPLES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 80: EUROPE: DRUG SCREENING MARKET FOR HAIR SAMPLES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 81: DRUG SCREENING MARKET FOR OTHER SAMPLES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 82: NORTH AMERICA: DRUG SCREENING MARKET FOR OTHER SAMPLES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 83: EUROPE: DRUG SCREENING MARKET FOR OTHER SAMPLES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 84: DRUG SCREENING MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 85: DRUG SCREENING MARKET FOR WORKPLACE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 86: NORTH AMERICA: DRUG SCREENING MARKET FOR WORKPLACE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 87: EUROPE: DRUG SCREENING MARKET FOR WORKPLACE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 88: DRUG SCREENING MARKET FOR CRIMINAL JUSTICE AND LAW ENFORCEMENT AGENCIES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 89: NORTH AMERICA: DRUG SCREENING MARKET CRIMINAL JUSTICE AND LAW ENFORCEMENT AGENCIES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 90: EUROPE: DRUG SCREENING MARKET CRIMINAL JUSTICE AND LAW ENFORCEMENT AGENCIES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 91: DRUG SCREENING MARKET FOR DRUG TREATMENT CENTERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 92: NORTH AMERICA: DRUG SCREENING MARKET FOR DRUG TREATMENT CENTERS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 93: EUROPE: DRUG SCREENING MARKET FOR DRUG TREATMENT CENTERS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 94: DRUG SCREENING MARKET FOR PAIN MANAGEMENT CENTERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 95: NORTH AMERICA: DRUG SCREENING MARKET PAIN MANAGEMENT CENTERS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 96: EUROPE: DRUG SCREENING MARKET PAIN MANAGEMENT CENTERS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 97: DRUG SCREENING MARKET FOR SCHOOLS AND COLLEGES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 98: NORTH AMERICA: DRUG SCREENING MARKET SCHOOLS AND COLLEGES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 99: EUROPE: DRUG SCREENING MARKET FOR SCHOOLS AND COLLEGES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 100: DRUG SCREENING MARKET FOR HOSPITALS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 101: NORTH AMERICA: DRUG SCREENING MARKET FOR HOSPITALS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 102: EUROPE: DRUG SCREENING MARKET FOR HOSPITALS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 103: DRUG SCREENING MARKET FOR INDIVIDUAL USERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 104: NORTH AMERICA: DRUG SCREENING MARKET FOR INDIVIDUAL USERS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 105: EUROPE: DRUG SCREENING MARKET FOR INDIVIDUAL USERS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 106: DRUG SCREENING MARKET FOR DRUG TESTING LABORATORIES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 107: NORTH AMERICA: DRUG SCREENING MARKET FOR DRUG TESTING LABORATORIES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 108: EUROPE: DRUG SCREENING MARKET FOR DRUG TESTING LABORATORIES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 109: GLOBAL DRUG SCREENING MARKET, BY REGION, 2015-2022, (USD MILLION)
  • TABLE 110: NORTH AMERICA: DRUG SCREENING MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 111: NORTH AMERICA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 112: NORTH AMERICA: DRUG SCREENING MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 113: NORTH AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 114: NORTH AMERICA: BREATHALYZERS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 115: NORTH AMERICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 116: NORTH AMERICA: URINE TESTING DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 117: NORTH AMERICA: CONSUMABLES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 118: NORTH AMERICA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
  • TABLE 119: NORTH AMERICA: DRUG SCREENING MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 120: US: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 121: US: DRUG SCREENING MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 122: US: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 123: US: BREATHALYZERS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 124: US: RAPID TESTING DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 125: US: URINE TESTING DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 126: US: CONSUMABLES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 127: US: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
  • TABLE 128: US: DRUG SCREENING MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 129: CANADA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 130: CANADA: DRUG SCREENING MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 131: CANADA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 132: CANADA: BREATHALYZERS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 133: CANADA: RAPID TESTING DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 134: CANADA: URINE TESTING DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 135: CANADA: CONSUMABLES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 136: CANADA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
  • TABLE 137: CANADA: DRUG SCREENING MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 138: EUROPE: DRUG SCREENING MARKET, BY COUNTRY, 2015-2022, (USD MILLION)
  • TABLE 139: EUROPE: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 140: EUROPE: DRUG SCREENING MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 141: EUROPE: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 142: EUROPE: BREATHALYZERS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 143: EUROPE: RAPID TESTING DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 144: EUROPE: URINE TESTING DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 145: EUROPE: CONSUMABLES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 146: EUROPE: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
  • TABLE 147: EUROPE: DRUG SCREENING MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 148: GERMANY: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 149: GERMANY: DRUG SCREENING MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 150: GERMANY: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 151: GERMANY: BREATHALYZERS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 152: GERMANY: RAPID TESTING DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 153: GERMANY: URINE TESTING DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 154: GERMANY: CONSUMABLES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 155: GERMANY: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
  • TABLE 156: GERMANY: DRUG SCREENING MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 157: FRANCE: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 158: FRANCE: DRUG SCREENING MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 159: FRANCE: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 160: FRANCE: BREATHALYZERS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 161: FRANCE: RAPID TESTING DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 162: FRANCE: URINE TESTING DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 163: FRANCE: CONSUMABLES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 164: FRANCE: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
  • TABLE 165: FRANCE: DRUG SCREENING MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 166: UK: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 167: UK: DRUG SCREENING MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 168: UK: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 169: UK: BREATHALYZERS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 170: UK: RAPID TESTING DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 171: UK: URINE TESTING DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 172: UK: CONSUMABLES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 173: UK: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
  • TABLE 174: UK: DRUG SCREENING MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 175: ROE: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 176: ROE: DRUG SCREENING MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 177: ROE: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 178: ROE: BREATHALYZERS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 179: ROE: RAPID TESTING DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 180: ROE: URINE TESTING DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 181: ROE: CONSUMABLES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 182: ROE: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
  • TABLE 183: ROE: DRUG SCREENING MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 184: APAC: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 185: APAC: DRUG SCREENING MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 186: APAC: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 187: APAC: BREATHALYZERS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 188: APAC: RAPID TESTING DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 189: APAC: URINE TESTING DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 190: APAC: CONSUMABLES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 191: APAC: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
  • TABLE 192: APAC: DRUG SCREENING MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 193: ROW: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 194: ROW: DRUG SCREENING MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 195: ROW: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 196: ROW: BREATHALYZERS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 197: ROW: RAPID TESTING DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 198: ROW: URINE TESTING DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 199: ROW: CONSUMABLES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 200: ROW: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
  • TABLE 201: ROW: DRUG SCREENING MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 202: MARKET RANKING (2016) BY KEY PLAYER: DRUG SCREENING SERVICES MARKET
  • TABLE 203: PRODUCT LAUNCHES AND APPROVALS
  • TABLE 204: EXCHANGE RATES (UTILIZED FOR CONVERSION OF JPY TO USD)

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY, DESIGNATION, AND REGION
  • FIGURE 3: BOTTOM UP APPROACH
  • FIGURE 4: TOP-DOWN APPROACH
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: DRUG SCREENING SERVICES MARKET TO OFFER SIGNIFICANT GROWTH OPPORTUNITIES
  • FIGURE 7: ANALYTICAL INSTRUMENTS TO DOMINATE THE DRUG SCREENING PRODUCTS MARKET IN 2017
  • FIGURE 8: ORAL FLUID SAMPLE TO WITNESS HIGH GROWTH DURING THE FORECAST PERIOD (2017-2022)
  • FIGURE 9: WORKPLACE DRUG TESTING TO DOMINATE THE DRUG SCREENING MARKET IN 2017
  • FIGURE 10: ASIA PACIFIC TO WITNESS HIGH GROWTH DURING THE FORECAST PERIOD
  • FIGURE 11: GROWING CONSUMPTION OF DRUGS AND ALCOHOL TO DRIVE THE GROWTH OF THE MARKET
  • FIGURE 12: RAPID TESTING DEVICES TO WITNESS HIGH GROWTH DURING THE FORECAST PERIOD
  • FIGURE 13: ASSAY KITS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF DRUG SCREENING CONSUMABLES MARKET IN 2017
  • FIGURE 14: ORAL FLUID SAMPLE SEGMENT TO WITNESS HIGH GROWTH DURING THE FORECAST PERIOD
  • FIGURE 15: CRIMINAL JUSTICE AND LAW ENFORCEMENT TO WITNESS HIGH GROWTH IN THE FORECAST PERIOD
  • FIGURE 16: US TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 17: DRUG SCREENING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 18: DRUG SCREENING MARKET SNAPSHOT, 2017 VS. 2022
  • FIGURE 19: DRUG SCREENING PRODUCTS MARKET SEGMENTATION
  • FIGURE 20: ANALYTICAL INSTRUMENTS TO DOMINATE THE DRUG SCREENING PRODUCTS MARKET IN 2017
  • FIGURE 21: BREATHALYZERS TO WITNESS HIGH GROWTH DURING THE FORECAST PERIOD
  • FIGURE 22: FUEL CELL BREATHALYZERS TO DOMINATE THE OVERALL BREATHALYZERS MARKET IN 2017
  • FIGURE 23: ASSAY KITS TO DOMINATE THE DRUG SCREENING CONSUMABLES MARKET IN 2017
  • FIGURE 24: URINE SAMPLES SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 25: WORKPLACES SEGMENT TO DOMINATE DRUG SCREENING MARKET DURING THE FORECAST PERIOD
  • FIGURE 26: NORTH AMERICA TO DOMINATE THE DRUG SCREENING MARKET IN 2017
  • FIGURE 27: NORTH AMERICA: DRUG SCREENING MARKET SNAPSHOT, 2017
  • FIGURE 28: EUROPE: DRUG SCREENING MARKET SNAPSHOT, 2017
  • FIGURE 29: ASIA PACIFIC (APAC): DRUG SCREENING MARKET SNAPSHOT, 2017
  • FIGURE 30: ROW: DRUG SCREENING MARKET SNAPSHOT, 2017
  • FIGURE 31: MARKET EVOLUTION FRAMEWORK
  • FIGURE 32: ALERE: COMPANY SNAPSHOT (2016)
  • FIGURE 33: THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2016)
  • FIGURE 34: DRAGERWERK: COMPANY SNAPSHOT (2016)
  • FIGURE 35: LABCORP: COMPANY SNAPSHOT (2016)
  • FIGURE 36: QUEST DIAGNOSTICS: COMPANY SNAPSHOT (2016)
  • FIGURE 37: LIFELOC: COMPANY SNAPSHOT (2016)
  • FIGURE 38: ORASURE: COMPANY SNAPSHOTS (2016)
  • FIGURE 39: PSYCHEMEDICS: COMPANY SNAPSHOT (2016)
  • FIGURE 40: ROCHE: COMPANY SNAPSHOT (2016)
  • FIGURE 41: SHIMADZU: COMPANY SNAPSHOT (2016)
  • FIGURE 42: SIEMENS: COMPANY SNAPSHOT (2016)
Back to Top